Eden Research plc First Mevalone authorisation for domestic use (1645O)

TIDMEDEN

RNS Number : 1645O

Eden Research plc

30 January 2023

30 January 2023

Eden Research Plc

("Eden" or "Company")

First Mevalone authorisation for domestic use

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that its flagship biofungicide, Mevalone(R) , has received authorisation for home garden use in Italy for the control of a number of important plant pathogens affecting the home grower. The diseases include Botrytis cinerea and powdery mildew, destructive fungal pathogens affecting many plant species.

Mevalone, which is marketed as 3LOGY(R) in Italy, is already approved for agricultural use across a wide range of crops including: wine and table grapes, tomatoes, apple, pears, strawberries, cucumber, and many more. Approval for 3LOGY has now been granted for domestic use across a number of crops, allowing retailers to sell 3LOGY to gardeners in Italy for home applications. The use of 3LOGY affords farmers and home growers maximum flexibility in their plant and crop protection as it is free from residues and provides them the important benefit of avoiding higher-than-permitted pesticide residue levels as stipulated by the regulatory authorities.

3LOGY is distributed exclusively in Italy by Eden's distribution partner, Sipcam-Oxon ("Sipcam"). Based on natural active ingredients, 3LOGY is a useful tool in plant protection programmes and is aligned with the demanding requirements of integrated pest management programmes. Sipcam has extensive experience with 3LOGY and has also supported significant label extensions in Spain and Portugal. This approval will enable Sipcam to expand the market for 3LOGY into homes across Italy.

For further information contact:

 
 Eden Research plc                                www.edenresearch.com 
 Sean Smith 
  Alex Abrey                                             01285 359 555 
 
 Cenkos Securities plc (Nominated advisor 
  and broker) 
 Giles Balleny / Max Gould (corporate 
  finance) 
  Michael Johnson (sales)                                020 7397 8900 
 
 Hawthorn Advisors (Financial PR) 
 Felix Meston                                [e-mail] 
  Simon Woods 
 

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market:

Based on plant-derived active ingredients, Mevalone(R) is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz(TM) is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's Sustaine(R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN, as well as in the United States on OTC under the symbol EDNSF. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit: www.edenresearch.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

REANKOBDOBKDFDB

(END) Dow Jones Newswires

January 30, 2023 02:00 ET (07:00 GMT)